Our Experts

Physician Profile

412-692-5081 Phone
412-692-5054 Fax

Kathryn S. Torok, MD

Job Title Assistant Professor, University of Pittsburgh School of Medicine
4401 Penn Avenue, Suite Floor 3
Pittsburgh, PA 15224
412-692-5081 Phone
412-692-5054 Fax

Education and Training

Medical School:

2004 The Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, PA


2006 Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA


2009 Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA


  • The Childhood Arthritis & Rheumatology Research Alliance (CARRA) 
  • The American College of Rheumatology (ACR)    
  • The American Academy of Pediatrics     
  • The Pennsylvania Medical Society     
  • The American Medical Association

Board Certifications

  • 2008 Board Certification in Pediatrics
  • 2011 Board Certification in Pediatric Rheumatology


  • Samuel & Emma Winters Foundation Grant, Scleroderma research  
  • America’s Top Pediatrician, Consumers’ Research Council of America 
  • Children’s Hospital of Pittsburgh of UPMC “Praise from Patients” Recognition 
  • Certificate of Appreciation, The 2007 Arthritis Walk Washington, Pennsylvania
  • The Marian J. Wettrick Charitable Foundation Grant   
  • The Class of 1971 Endowed Scholarship Award    
  • Jean Phillips Shibley Memorial Biology Scholarship   
  • National Science Foundation Student Research Grant   
  • Howard Hughes Undergraduate Biology Scholarship


  • Li, Suzanne; Torok, Kathryn; Pope, Elena; Dedeoglu, Fatma; Hong, Sandy; Jacobe, Heidi; Rabinovich, Egla; Laxer, Ronald M.; Higgins, Gloria; Ferguson, Polly; Lasky, Drew; Baszis, Kevin; Becker, Mara; Campillo, Sarah; Cartwright, Virginia; Cidon, Michal; Inman, Christi; Jerath, Rita; O'Neil, Kathleen; Vora, Sheetal; Zeft, Andrew; Wallace, Carol; Ilowite, Norman; Fuhlbrigge, Robert.  Development of Consensus Treatment Plans for Juvenile Localized Scleroderma. Arthritis Care Res. 2012 Aug;64(8):1175-1185. doi: 10.1002/acr.21687. PMID: 22505322
  • Torok KS.  Chapter 9: Scleroderma in Children and Adolescents.  In: Pediatric Clinics of North America. Editor: Ronald Laxer.  London, England; Elsevier 2012 Apr;59(2):381-405. PMID:  22560576.  NIHMS368913.
  • Torok KS and Rosen P. Chapter 8: Pediatric Rheumatology.  In: Zitelli and Davis' Atlas of Pediatric Physical Diagnosis 6th edition.  Editor: Basil Zitelli. London, England; Elsevier; 2012. Chapter 8, 259-298.

    View Dr. Torok's full list of publications from PubMed.

Biography Summary

Kathryn Torok, MD, began her career in Pediatric Rheumatology as a Fellow at the Children’s Hospital of Pittsburgh in 2006.  Upon completion of her fellowship, she started as an Instructor in the Division of Rheumatology Pittsburgh in July 2009, and was promoted to Assistant Professor in July 2010. She helped create, implement, and now serves as director of the CHP Scleroderma Clinic which provides treatment for children with localized and systemic scleroderma (LS and ScS).
Along with treating patients, Dr. Torok has been involved in a multitude of research projects including serving as principle investigator and coordinator of the National Registry for Childhood Onset Scleroderma.  The registry serves as a national resource of longitudinal data on pediatric patients with this disease and spurs Dr. Torok’s mission to directly stimulate new research and investigations with this patient population.  In addition to the registry, Dr. Torok is involved in the Childhood Arthritis and Rheumatic Disease Research Alliance Network (CARRANet), a North American organization of pediatric rheumatologists who are committed to advancing the health and quality of life of children living with rheumatic disease and arthritis and who have joined together to answer critical clinical research questions.  She has initiated and participated in a number of studies to further evaluate disease activity measurement in pediatric localized scleroderma, by studying clinical, thermal and ultrasonography measures. 
Currently, Dr. Torok’s main research interest is the T-helper cell cytokine profile of patients with localized scleroderma.  Her NIH funded project represents the first study to evaluate all three Th cell lineages in LS by measuring their associated cytokines in serum and skin biopsies of patients.  Effective anti-cytokine therapies for LS may stem from this proposal, modifying the way clinicians treat this disease and potentially saving children from life-long physical and emotional disability.
Dr. Torok’s long-term research goal is to provide better treatment options for LS by targeting cytokines and other factors associated with the active phase of the disease, to minimize or prevent long-term tissue damage.

Active Research Projects / Grants

  • NIH K23 (PI): T-helper cell cytokine profile in localized scleroderma
  • The Nancy Taylor Foundation for Chronic Diseases (PI): Serum cytokine profiles in localized scleroderma
  • NIH (PI of Pittsburgh site): Childhood Arthritis and Rheumatic Disease Research Alliance Network (“CARRANet”): Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology
  • “Development of Clinical Disease Activity Measures for Pediatric Localized Scleroderma”
    Sponsor: The Arthritis Foundation and Hackensack University Medical Center     1/1/2009 – 6/30/2013
    Role:  Study Site (University of Pittsburgh) Principal Investigator; Coordinating Center: Hackensack University Medical Center
  • “Developing Tools for Localized Scleroderma Comparative Effectiveness Studies”
    Sponsor: Arthritis Foundation
    3/1/2012 – 2/28/2014 
    Role: Study Site (University of Pittsburgh) Principal Investigator
Last Update
August 28, 2012
  • Increase/Decrease Text Size
  • Print This Page
Last Update
August 28, 2012